The Search for Pharmacologically Active Compounds Among the 2-Dialkylaminobenzimidazoles


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Heating of substituted benzimidazole-2-sulfonic acids in the presence of excess quantities of secondary amines was used to synthesize dialkylaminobenzimidazoles. Experimental studies of potential antiarrhythmic, antiaggregation, hemorheological, AT1 angiotensin- and NHE-1-inhibiting, and antiserotonin activity identified active compounds. 1[-2-(5-Methyl)benzimidazole]pyrrolidine had greater NHE-inhibiting activity than zoniporide. 1-{[2-(5-Methoxy)benzimidazole]-4-N-methyl}piperazine dihydrochloride had greater antiaggregatory activity than acetylsalicylic acid, while 1-[2-(5-methyl)benzimidazole]piperidine was as active as cyproheptadine in terms of 5-HT2A antagonistic activity. 1-(2-Benzimidazole)pyrrolidine and 1-[2-(5-chloro) benzimadazole pyrrolidine dihydrochlorides had 5-HT3 antagonist activity equal to that of tropisetron..

作者简介

O. Zhukovskaya

Science Research Institute of Physical and Organic Chemistry, Southern Federal University

编辑信件的主要联系方式.
Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Rostov-on-Don

V. Anisimova

Science Research Institute of Physical and Organic Chemistry, Southern Federal University

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Rostov-on-Don

A. Spasov

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd; Volgograd

D. Yakovlev

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd; Volgograd

N. Gurova

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd

A. Kucheryavenko

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd

O. Salaznikova

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd

V. Kuznetsova

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd; Volgograd

D. Mal’tsev

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd; Volgograd

A. Brigadirova

Volgograd State Medical University, Ministry of Health of the Russian Federation; Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd; Volgograd

Ya. Morkovina

Volgograd Medical Scientific Center

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd

O. Solov’eva

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd

V. Gurova

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd

E. Reznikov

Volgograd State Medical University, Ministry of Health of the Russian Federation

Email: zhukowskaia.ol@yandex.ru
俄罗斯联邦, Volgograd


版权所有 © Springer Science+Business Media, LLC, 2017
##common.cookie##